Expertise in
34
conditions

Vincenzo Leuzzi

Rome, IT 
Expertise in
34
conditions
Rome, IT 

Overview

Vincenzo Leuzzi practices practicing medicine in Rome, Italy.

Mr. Leuzzi is highly rated in 34 conditions, according to our data. His clinical expertise encompasses Phenylketonuria (PKU), Drug Induced Dyskinesia, Movement Disorders, Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency, and Deep Brain Stimulation.

He is actively involved in clinical research, co-authoring 218 peer reviewed articles and participating in 3 clinical trials.

Gender

Male

Locations

Rome, Italy
Other Locations
Sapienza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
A Phase 3 Open-Label Study of PTC923 (Sepiapterin) in Phenylketonuria
Enrollment Status: Active_not_recruiting
Publish Date: June 23, 2026
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Multi-center, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects of Intra-Erythrocyte Dexamethasone Sodium Phosphate on Neurological Symptoms in Patients With Ataxia Telangiectasia
Enrollment Status: Completed
Publish Date: May 10, 2024
Intervention Type: Drug
Study Drugs: Autologous Erythrocytes, Dexamethasone Sodium Phosphate
Study Phase: Phase 3
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
A Phase 3 Study of PTC923 in Subjects With Phenylketonuria
Enrollment Status: Completed
Publish Date: January 10, 2024
Intervention Type: Drug
Study Drug: PTC923
Study Phase: Phase 3
View 2 Less Clinical Trials

218 Total Publications

Gene supplementation therapy restores motor deficits in Gnao1[C215Y] mice and proves broad efficacy in C. elegans model.
Gene supplementation therapy restores motor deficits in Gnao1[C215Y] mice and proves broad efficacy in C. elegans model.
Journal: Acta neuropathologica communications
Published: May 06, 2026

Frequently Asked Questions about Vincenzo Leuzzi

Is Vincenzo Leuzzi a top-rated expert for Phenylketonuria (PKU)?

MediFind is an objective health platform that identifies experts based on real-world data. Vincenzo Leuzzi is classified as an Elite expert for Phenylketonuria (PKU), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Vincenzo Leuzzi participate in research or clinical trials?

Yes. Vincenzo Leuzzi has published 218 articles and abstracts on conditions like Phenylketonuria (PKU). You can view a list of Vincenzo Leuzzi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Leuzzi's expertise for a condition
ConditionClose
View All 7 Distinguished Conditions
View All 25 Advanced Conditions
View All 52 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile